Immune system | |||||
---|---|---|---|---|---|
Immune system / Immune system disorders and transplantation | |||||
antithymocyte immunoglobulin (rabbit) | HOSPITAL ONLY PRESCRIBING |
NICE TA481 |
|||
Solution for infusion | |||||
Antithymocyte immunoglobulin (rabbit) (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Powder and solvent for solution for infusion | |||||
Thymoglobulin (Sanofi) | HOSPITAL ONLY PRESCRIBING | ||||
avacopan | HOSPITAL ONLY PRESCRIBING |
NICE TA825 |
|||
Avacopan for Severe active granulomatosis with polyangiitis or microscopic polyangiitis (TA825)
Adults. Avacopan with a cyclophosphamide or rituximab regimen is recommended, within its marketing authorisation |
|||||
azathioprine | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
AZATHIOPRINE - HOSPITAL ONLY INDICATIONS
Azathioprine is HOSPITAL ONLY for SEVERE ATOPIC DERMATITIS and RENAL TRANSPLANTATION |
|||||
basiliximab | HOSPITAL ONLY PRESCRIBING |
NICE TA481 |
|||
Powder and solvent for solution for injection | |||||
Simulect (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
belatacept | HOSPITAL ONLY PRESCRIBING |
NICE TA481 |
|||
belimumab | HOSPITAL ONLY PRESCRIBING |
NICE TA752 |
|||
Powder for solution for infusion | |||||
Benlysta (GlaxoSmithKline UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
canakinumab | HOSPITAL ONLY PRESCRIBING | ||||
Solution for injection | |||||
Ilaris (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
ciclosporin | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines |
NICE TA369 |
|||
CICLOSPORIN (NEORAL)
Ciclosporin (Neoral) is HOSPITAL ONLY for renal transplant patients and severe resistant childhood psoriasis and atopic eczema |
|||||
Oral solution | |||||
Neoral (Novartis Pharmaceuticals UK Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Sandimmun (Novartis Pharmaceuticals UK Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Solution for infusion | |||||
Sandimmun (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
everolimus | HOSPITAL ONLY PRESCRIBING |
NICE TA421 NICE TA432 NICE TA449 |
|||
Afinitor® NICE TA498 Certican® NICE TA348 Certican® NICE TA481 |
|||||
hydroxychloroquine sulfate | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
mycophenolate mofetil | HOSPITAL ONLY PRESCRIBING |
NICE TA481 NICE TA481 |
|||
Formulary Status
Mycophenolate Mofetil is HOSPITAL ONLY for organ transplantation Mycophenolate is AMBER (specialist recommended and initiated – primary care to continue with no Shared Care Guidelines) for immune system disorders |
|||||
Gastro-resistant tablet | |||||
Mycophenolate mofetil (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Ceptava (Sandoz Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Myfortic (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
A formal Shared Care Guideline (SCG) may be available.
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. |
|||||
Oral suspension | |||||
CellCept (Roche Products Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
rituximab | HOSPITAL ONLY PRESCRIBING |
NICE TA308 NICE TA195 NICE TA243 NICE TA137 NICE TA193 NICE TA226 NICE TA174 NICE TA359 NICE TA561 |
|||
Solution for injection | |||||
MabThera (Roche Products Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Solution for infusion | |||||
MabThera (Roche Products Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Rixathon (Sandoz Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Truxima (Celltrion Healthcare UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
sirolimus | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines |
NICE TA481 |
|||
Oral solution | |||||
Rapamune (Pfizer Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
tacrolimus | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines |
NICE TA82 NICE TA481 NICE TA481 |
|||
TACROLIMUS IN RENAL TRANSPLANTATION
Tacrolimus is HOSPITAL ONLY for use inr enal transplantation |
|||||
TACROLIMUS
Tacrolimus is HOSPITAL ONLY for renal transplantation |
|||||
Modified-release tablet | |||||
Envarsus (Chiesi Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Modified-release capsule | |||||
Advagraf (Astellas Pharma Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Solution for infusion | |||||
Prograf (Astellas Pharma Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Immune system / Multiple sclerosis | |||||
alemtuzumab | HOSPITAL ONLY PRESCRIBING |
NICE TA312 |
|||
Solution for infusion | |||||
Lemtrada (Sanofi) | HOSPITAL ONLY PRESCRIBING | ||||
cladribine | HOSPITAL ONLY PRESCRIBING |
NICE TA616 |
|||
Solution for injection | |||||
Litak (Lipomed GmbH) | HOSPITAL ONLY PRESCRIBING | ||||
Solution for infusion | |||||
Leustat (Atnahs Pharma UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
dimethyl fumarate | HOSPITAL ONLY PRESCRIBING | ||||
Skilarence® NICE TA475 Tecfidera® NICE TA320 |
|||||
Gastro-resistant tablet | |||||
Skilarence (Almirall Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Gastro-resistant capsule | |||||
Tecfidera (Biogen Idec Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
fampridine | HOSPITAL ONLY PRESCRIBING | ||||
Modified-release tablet | |||||
Fampyra (Biogen Idec Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
fingolimod | HOSPITAL ONLY PRESCRIBING |
NICE TA254 |
|||
glatiramer acetate | HOSPITAL ONLY PRESCRIBING |
NICE TA527 |
|||
Solution for injection | |||||
Brabio (Viatris UK Healthcare Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Copaxone (Teva UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
interferon beta | HOSPITAL ONLY PRESCRIBING |
NICE TA527 NICE TA527 |
|||
Solution for injection | |||||
Avonex (Biogen Idec Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Rebif (Merck Serono Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Powder and solvent for solution for injection | |||||
Betaferon (Bayer Plc) | HOSPITAL ONLY PRESCRIBING | ||||
Extavia (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
natalizumab | HOSPITAL ONLY PRESCRIBING |
NICE TA127 |
|||
Solution for infusion | |||||
Tysabri (Biogen Idec Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
ocrelizumab | HOSPITAL ONLY PRESCRIBING |
NICE TA533 NICE TA585 |
|||
peginterferon beta-1a | HOSPITAL ONLY PRESCRIBING |
NICE TA624 |
|||
Solution for injection | |||||
Plegridy (Biogen Idec Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
ponesimod | HOSPITAL ONLY PRESCRIBING |
NICE TA767 |
|||
teriflunomide | HOSPITAL ONLY PRESCRIBING |
NICE TA303 |
|||
Immune system / Autoimmune hepatitis | |||||
budesonide | HOSPITAL ONLY PRESCRIBING |
NICE TA708 |
|||
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |